Patients were stratified according to PSA levels as follow: Group 1 PSA < 0.2 ng/ml. Group 2 PSA > 0.2 ng/ml. Patients were stratified also according to surgical margin specimen and pT stages. Agreement evaluation was performed. Telephone follow-up satisfaction was assessed by VAS scale.RESULTS: All patients with PSA < 0.2 ng/ml had negative DRE with agreement of 100%. Pts with PSA > 0.2 ng/ml had a positive DRE in 3/34, all pts with PSA <4 ng/ml. The concordance between DRE and PSA in non-biochemical recurrence patients was 100% (461/461), while the concordance between DRE and PSA in biochemical recurrence patients was 8.8% (3/34). Surgical margin specimen and pT stages did not influenced DRE results (Table 1). The patient management between telephone follow-up and in clinic evaluation did not change in all cases with PSA <0.2, while in case of biochemical recurrence could change in 8.8%. Satisfaction rate was high (82%). Stratification of patients according with DRE and PSA levels is reported in table 2.CONCLUSIONS: Telephone follow-up was feasible and reliable in the management of males without biochemical recurrence after RP. While, in case of biochemical recurrence an office evaluation is advisable. Telephone follow-up had high patients' satisfaction rate.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.